Immune checkpoint inhibitor plus anti-HER2 therapy: a new standard for HER2-positive oesophagogastric cancer?
作者信息
Narita Yukiya, Kadowaki Shigenori, Muro Kei
机构信息
Department Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 4648681, Japan.
Department Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 4648681, Japan.
出版信息
Lancet Oncol. 2020 Jun;21(6):741-743. doi: 10.1016/S1470-2045(20)30208-4. Epub 2020 May 18.
Abstract
摘要
Zotero 插件